Although AMLs with the NPM1 mutations nearly always express HOXA genes, it is unclear whether HOXA expression in these cells shares similar regulatory factors and chromatin structures that appear to be critical for HOXA expression in MLL-rearranged AML cells. The gene discussed is KMT2A; the disease is acute myeloid leukemia.